Complement C1 Esterase Inhibitor, Serum
Test ID:
704793
CPT code:
86160
Synonyms:
Complement C1 Esterase Inhibitor
C1 Esterase Inhibitor, Antigen
C1 Inactivator
C1 Inhibitor
Esterase Inhibitor
HANE Assay
Hereditary Angioneurotic Edema Test
Clinical Use:
C1 esterase inhibitor is decreased in hereditary angioneurotic edema; decrease may be functional or quantitative
Test Information:
The more common form (85% of patients) of hereditary angioneurotic edema is due to an absolute decrease in the amount of C1 esterase inhibitor. A less common form (15% of patients) is due to a functional defect where quantitative levels may be normal. Both abnormalities must be tested for due to the potential life-threatening nature of the illness.
In addition to decreased C1 esterase inhibitor in the serum of patients with hereditary angioneurotic edema, a unique polypeptide kinin is increased in plasma from C1 esterase inhibitor deficient patient during attacks of swelling. Danazol, a synthetic androgenic inhibitor of gonadotropin release, with little virilizing potential, decreases the number of clinical attacks in cases of hereditary angioneurotic edema. Patients with attacks of hereditary angioneurotic edema also have low total complement, C4 and C2. Consequently, measurement of serum C4 is an often used test. Hereditary angioneurotic edema is transmitted as an autosomal dominant trait. Heterozygotes also show decreased levels of C1 esterase inhibitor. During acute attacks of the disease, complement factors C4 and C2 can be markedly reduced, but C1 and C3 are normal. The initiating stimulus of clinical attacks is often unknown.
Angioedema may also be an acquired illness. The acquired form includes nonhereditary C1 esterase deficiency; drug induced, allergic, and idiopathic forms, angioedema associated with autoimmune disease, especially with systemic lupus erythematosus and hypereosinophilia; angioedema occasionally associated with malignancy; and angioedema caused by physical stimuli. Angioedema has occasionally been known to precede development of lymphoproliferative disorders.
Specimen Type:
Serum
Requested Volume:
1 mL
Minimum Volume:
0.5 mL
Container Type:
Red-top tube or gel-barrier tube
Collection:
Separate serum from cells within 30 to 60 minutes after collection. Transfer specimen to a plastic transport tube.
Storage Instructions:
Maintain specimen at room temperature.
Stability Requirements:
Temperature |
Period |
---|---|
Room temperature |
14 days |
Refrigerated |
14 days |
Frozen |
14 days |
Freeze/thaw cycles |
Stable x3 |
Rejection Criteria
Microbially-contaminated samples; hemolysis; gross lipemia that cannot be cleared by ultracentrifugation; citrated plasma (heparinized plasma is acceptable)
Return Back to Test Directory
MCI Diagnostic
Providing top patient care with fast results.
7018 South Utica Avenue
Tulsa, Oklahoma 74136
Hours of Operation
Mon - Sat: 7 AM-11 PM
Sun: 7 AM-3 PM
COVID-19 Drive-Thru Hours
Mon-Fri: 9 AM-6 PM
Sat: 9 AM-3 PM
More Information - Click Here
Government Contract
DUNS # 125722608
Cage Code: 3FPQ3
COVID-19
COVID-19 Fee & Pricing